Drug search by name

Hyoscyamine, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic and Liver disease

Result of checking the interaction of drug Hyoscyamine, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic and disease Liver disease for safety when used together.

Check result:

Hyoscyamine, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic <> Liver disease

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of methenamine and its salts (i.e. methenamine hippurate or mandelate) is contraindicated in patients with severe hepatic impairment. Methenamine is hydrolyzed to ammonia and formaldehyde in the urine under acidic conditions. Patients with liver disease may already have elevated ammonia levels, which can cause or exacerbate hepatic encephalopathy. Methenamine hippurate has also been associated with isolated cases of transient elevations in serum transaminases. The manufacturer recommends periodic liver function tests during therapy, particularly in patients with preexisting liver dysfunction.

References:

Strom J, Jun H "Kinetics of hydrolysis of methenamine." Pharm Bull 23 (1975): 651
"Product Information. Mandelamine (methenamine)." Parke-Davis, Morris Plains, NJ.
Gleckman R, Alvarez S, Joubert D, Matthews S "Drug therapy reviews: methenamine mandelate and methenamine hippurate." Am J Hosp Pharm 36 (1979): 1509-12
"Product Information. Hiprex (methenamine)." Hoechst Marion-Roussel Inc, Kansas City, MO.
American Medical Association, Division of Drugs and Toxicology "Drug evaluations annual 1994." Chicago, IL: American Medical Association; (1994):

Hyoscyamine, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic

Generic Name: hyoscyamine / methenamine / methylene blue / sodium biphosphate

Brand Name: Urogesic-Blue, UTA, Uro-BLUE, Urolet MB, Indiomin MB, ME/NaPhos/MB/Hyo1, UTA

Synonyms: Hyoscyamine, methenamine, methylene blue, and sodium biphosphate

What is Hyoscyamine, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic?

Another drug Delete

Hyoscyamine, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic <> Liver disease

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

Consumer:

Atropine-like agents undergo significant hepatic metabolism. Therapy with atropine-like agents should be administered cautiously to patients with liver disease.

References: